Showing 2 of 10 years of data. Sign up free for 3 years, or upgrade for full access.
View PlansCash Conversion
1.17x
IPCALAB's operating cash flow exceeded net income in FY 2025, indicating earnings are backed by actual cash generation.
Free Cash Flow
₹5.46B
IPCALAB's free cash flow was ₹5.46B in FY 2025, up 2.2% from FY 2024.
Dividend Coverage
5.4x
IPCALAB's free cash flow covered dividends 5.4x in FY 2025, leaving room for reinvestment or debt reduction.
CapEx Intensity
58.7%
Capital expenditure was 58.7% of operating cash flow in FY 2025 for IPCALAB, a moderate level of reinvestment.
Hover the chart icon for YoY change.
| Item | Chart | 2024 | 2025 |
|---|---|---|---|
| Net Income | 8.43B | 11.31B | |
| Cash flow Operating Activities | 9.45B | 13.21B | |
| Investments in PPE | -4.11B | -7.76B | |
| Cash flow Investing Activities | -12.92B | -8.70B | |
| Dividend Paid | -507.40M | -1.01B | |
| Cash flow Financing Activities | -5.53B | -2.83B | |
| Cash at beginning of period | 15.79B | 7.56B | |
| Cash at end of period | 7.56B | 9.25B | |
| Free Cash Flow | 5.34B | 5.46B |
Values are shown in millions (M) and billions (B). All amounts are in Indian Rupees (₹).
Data from audited consolidated filings. For educational purposes only — not investment advice. Last update: Mar-2025